Urologie

Semi-Live • Heidelberg • 2024 youtu.be/pSHGI1_op5Y

Semi-Live 2022 GLOBAL (March 2-5, 2022): Join wherever you are! State of the Art in Urologic Surgery: View, discuss, reflect, contemplate, chat and earn CME's! Limitless due to opportunity! Program and Registration: semi-live.org youtube.com/watch?v=KGmR6W…

@iUrology twitter.com/Urologie/statu…

@iUrology twitter.com/Semi_Live/stat…

Invitation to “Semi-Live 2022” in Heidelberg! Registration is open! Early bird discount until December 15, 2021. All info here: semi-live.org

Semi-Live March 2022 in Heidelberg

State-of-the-art staging of high risk prostate cancer for subsequent local therapy: replacement of CT and bone scan by PSMA-PET. thelancet.com/journals/lance…

Radiotherapy (RT) following radical prostatectomy: early salvage RT (PSA 0.2 ng/ml) vs.adjuvant RT reduces over-treatment by 50% with concomitant reduction of functional morbidities without compromising oncological safety. thelancet.com/journals/lanon…

"Telephone": Multilateral Communication Management in Clinical Medicine nejm.org/doi/full/10.10…

Epigenetics of the fetal prostate and their association with metastatic prostate cancer nejm.org/doi/full/10.10…

RAVES or the end of adjuvant radiotherapy in high-risk prostate cancer: early salvage radiotherapy +/- equally effective if delivered at a PSA of < / = 0.2. PS: Indicate PSMA-PET in BCR! thelancet.com/pdfs/journals/…

TREXIT?: Needle track seeding of prostate cancer after transrectal prostate biopsy. reader.elsevier.com/reader/sd/pii/…

RPx With vs. Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk PCa improved: event-free (e.g. death, progression, additional treatment), metastatic free, & overall survival. Did not improve 3-year biochemical progression-free survival. ascopubs.org/doi/pdf/10.120…

Die Urologie in Zeiten von Corona | Mit Prof. Dr. Markus Hohenfellner | ... youtu.be/z-ywJvu1ruo via @YouTube

🍀‼️ nature.com/articles/d4158…

Precision oncology beats high-end standard care in Prostate Cancer: nejm.org/doi/full/10.10…

DARULTAMIDE 4 NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: => reduces the risk of death by 30% => vs. placebo comparable adverse events nejm.org/do/10.1056/NEJ…

Similar pathways of compromized immunology in critical virus infections vs. critical cancers: a possible role of T cell - increased PD-1 expression. With a perspective of new indications for Checkpoint Inhibitors? Sattler, Kotsch et al. (Charité 2020) jci.org/articles/view/…